Skip to main content
Ciulli Laboratory
School of Life Sciences, University of Dundee
Main menu
Home
Alessio Ciulli
Research
Group
Publications
Positions
News
Contact
Home
Alessio Ciulli
Research
Targeted Protein Degradation: PROTACs
Cullin RING E3 Ubiquitin Ligases
Chromatin-Reader Domains
Fragment-Based Ligand Discovery
Chemical Probes
Group
Past Group Members
Past Group Photos
Ciulli Lab Cards
Group Achievements
Publications
Journal Club
Positions
Postdoctoral Scientists
Postgraduate Studentships
Visiting PhD Students
Summer studentships / Internships
News
Contact
News
December 2022
Amphista receives investment that raises hopes of new dementia treatments
November 2022
Successful anti-cancer alliance extended
Alessio participates to online seminar "Illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACB1
Study raises hopes of preventing resistance in cancer therapy
October 2022
Discovery raises hopes of further anti-cancer breakthroughs
September 2022
Amphista therapeutics opens Cambridge's Granta Park research facility and is named “Fierce 15” Biotech Companies of 2022
August 2022
Research breakthrough will help develop future treatments against Parkinson’s disease
Now published in Chemical Society Reviews: Claudia & Alessio's review on VHL ligands and their use as VHL inhibitors and in PROTAC degraders
July 2022
Tag tech collaboration to battle undruggable diseases
SULSA funding success for early career researchers
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
